U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C48H95NO3
Molecular Weight 734.2728
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of N-Triacontanoyl-D-erythro-sphingosine

SMILES

CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC

InChI

InChIKey=YTMSJWGKIOCDQT-NJLCVJHMSA-N
InChI=1S/C48H95NO3/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-25-26-27-28-29-30-32-34-36-38-40-42-44-48(52)49-46(45-50)47(51)43-41-39-37-35-33-31-16-14-12-10-8-6-4-2/h41,43,46-47,50-51H,3-40,42,44-45H2,1-2H3,(H,49,52)/b43-41+/t46-,47+/m0/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
C30 Ceramide (d18:1/30:0)
Preferred Name English
N-Triacontanoyl-D-erythro-sphingosine
Systematic Name English
N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]triacontanamide
Systematic Name English
C30-Ceramide
Common Name English
Triacontanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
Systematic Name English
Code System Code Type Description
CAS
871540-97-5
Created by admin on Wed Apr 02 20:31:33 GMT 2025 , Edited by admin on Wed Apr 02 20:31:33 GMT 2025
PRIMARY
PUBCHEM
137700177
Created by admin on Wed Apr 02 20:31:33 GMT 2025 , Edited by admin on Wed Apr 02 20:31:33 GMT 2025
PRIMARY
FDA UNII
4Y6SC8LHH3
Created by admin on Wed Apr 02 20:31:33 GMT 2025 , Edited by admin on Wed Apr 02 20:31:33 GMT 2025
PRIMARY